Generic Advair's Labeling Variation Stems From Permissible Design Differences, US FDA Says

Concept of absolute parity with two same size balls but different color in perfect balance on a balance.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics